Metagenomic editing of commensal bacteria in vivo using CRISPR-associated transposases.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41231980.
- Also identified by DOI 10.1126/science.adx7604 and PMC identifier 12969935.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although metagenomic sequencing has revealed a rich microbial biodiversity in the mammalian gut, methods to genetically alter specific species in the microbiome are highly limited. Here, we introduce Metagenomic Editing (MetaEdit) as a platform technology for microbiome engineering that uses optimized CRISPR-associated transposases delivered by a broadly conjugative vector to directly modify diverse native commensal bacteria from mice and humans with new pathways at single-nucleotide genomic resolution. Using MetaEdit, we achieved in vivo genetic capture of native murine <i>Bacteroides</i> by integrating a metabolic payload that enables tunable growth control in the mammalian gut with dietary inulin. We further show in vivo editing of segmented filamentous bacteria, an immunomodulatory small-intestinal microbial species recalcitrant to cultivation. Collectively, this work provides a paradigm to precisely manipulate individual bacteria in native communities across gigabases of their metagenomic repertoire.
Medical subject headings
- Gastrointestinal Microbiome
- Gene Editing
- Bacteroides
- CRISPR-Cas Systems